1. Background
2. The Pivotal Role of IL-6 and TNF-α in Lung Infections
3. Adiponectin Function in Lung Infections
4. ω-3 PUFAs and Lung Infections
5. Other Dietary Constituents and Lung Infections
6. Discussion and Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Banerjee, A.; Kulcsar, K.; Misra, V.; Frieman, M.; Mossman, K. Bats and coronaviruses. Viruses 2019. [Google Scholar] [CrossRef] [PubMed]
- Schoeman, D.; Fielding, B.C. Coronavirus envelope protein: Current knowledge. Virol. J. 2019. [Google Scholar] [CrossRef] [PubMed]
- Fehr, A.R.; Perlman, S. Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses: Methods and Protocols; The Pirbright Institute: Surrey, UK, 2015. [Google Scholar] [CrossRef]
- Yamaya, M.; Nishimura, H.; Deng, X.; Sugawara, M.; Watanabe, O.; Nomura, K.; Shimotai, Y.; Momma, H.; Ichinose, M.; Kawase, T. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir. Investig. 2020. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Li, H.; Fan, R.; Wen, B.; Zhang, J.; Cao, X.; Wang, C.; Song, Z.; Li, S.; Li, X.; et al. Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children. Intervirology 2017. [Google Scholar] [CrossRef]
- Xu, Z.; Shi, L.; Wang, Y.; Zhang, J.; Huang, L.; Zhang, C.; Liu, S.; Zhao, P.; Liu, H.; Zhu, L.; et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020. [Google Scholar] [CrossRef]
- Tian, S.; Hu, W.; Niu, L.; Liu, H.; Xu, H.; Xiao, S.-Y. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J. Thorac. Oncol. 2020. [Google Scholar] [CrossRef]
- Pan, F.; Ye, T.; Sun, P.; Gui, S.; Liang, B.; Li, L.; Zheng, D.; Wang, J.; Hesketh, R.L.; Yang, L.; et al. Time Course of Lung Changes on Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology 2020. [Google Scholar] [CrossRef]
- Tse, G.M.K.; To, K.F.; Chan, P.K.S.; Lo, A.W.I.; Ng, K.C.; Wu, A.; Lee, N.; Wong, H.C.; Mak, S.M.; Chan, K.F.; et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J. Clin. Pathol. 2004. [Google Scholar] [CrossRef]
- Baud, D.; Qi, X.; Nielsen-Saines, K.; Musso, D.; Pomar, L.; Favre, G. Real estimates of mortality following COVID-19 infection. Lancet Infect. Dis. 2020. [Google Scholar] [CrossRef]
- Remuzzi, A.; Remuzzi, G. COVID-19 and Italy: What next? Lancet 2020. [Google Scholar] [CrossRef]
- Ruan, Q.; Yang, K.; Wang, W.; Jiang, L.; Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. [Google Scholar] [CrossRef] [PubMed]
- Addi, A.B.; Lefort, A.; Hua, X.; Libert, F.; Communi, D.; Ledent, C.; Macours, P.; Tilley, S.L.; Boeynaems, J.M.; Robaye, B. Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor. Eur. J. Immunol. 2008. [Google Scholar] [CrossRef]
- Guo, Y.-R.; Cao, Q.-D.; Hong, Z.-S.; Tan, Y.-Y.; Chen, S.-D.; Jin, H.-J.; Tan, K.-S.; Wang, D.-Y.; Yan, Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—An update on the status. Mil. Med. Res. 2020, 7, 11. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, T.; Narazaki, M.; Kishimoto, T. Il-6 in inflammation, Immunity, And disease. Cold Spring Harb. Perspect. Biol. 2014. [Google Scholar] [CrossRef] [PubMed]
- Velazquez-Salinas, L.; Verdugo-Rodriguez, A.; Rodriguez, L.L.; Borca, M.V. The role of interleukin 6 during viral infections. Front. Microbiol. 2019. [Google Scholar] [CrossRef]
- Monda, V.; Carotenuto, M.; Precenzano, F.; Iacono, D.; Messina, A.; Salerno, M.; Sessa, F.; Lanzara, V.; Messina, G.; Quatrosi, G.; et al. Neuropeptides’ Hypothalamic Regulation of Sleep Control in Children Affected by Functional Non-Retentive Fecal Incontinence. Brain Sci. 2020. [Google Scholar] [CrossRef]
- Robb, C.T.; Regan, K.H.; Dorward, D.A.; Rossi, A.G. Key mechanisms governing resolution of lung inflammation. Semin. Immunopathol. 2016. [Google Scholar] [CrossRef]
- Agriesti, F.; Tataranni, T.; Pacelli, C.; Scrima, R.; Laurenzana, I.; Ruggieri, V.; Cela, O.; Mazzoccoli, C.; Salerno, M.; Sessa, F.; et al. Nandrolone induces a stem cell-like phenotype in human hepatocarcinoma-derived cell line inhibiting mitochondrial respiratory activity. Sci. Rep. 2020, 10, 2287. [Google Scholar] [CrossRef]
- Seo, S.H.; Webster, R.G. Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells. J. Virol. 2002. [Google Scholar] [CrossRef]
- Lundblad, L.K.A.; Thompson-Figueroa, J.; Leclair, T.; Sullivan, M.J.; Poynter, M.E.; Irvin, C.G.; Bates, J.H.T. Tumor necrosis factor-α overexpression in lung disease: A single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005, 171, 1363–1370. [Google Scholar] [CrossRef]
- Qiao, L.Y.; Goldberg, J.L.; Russell, J.C.; Xiao Jian, S. Identification of enhanced serine kinase activity in insulin resistance. J. Biol. Chem. 1999, 274, 10625–10632. [Google Scholar] [CrossRef] [PubMed]
- Wisse, B.E. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J. Am. Soc. Nephrol. 2004. [Google Scholar] [CrossRef] [PubMed]
- Bafunno, V.; Divella, C.; Sessa, F.; Tiscia, G.L.; Castellano, G.; Gesualdo, L.; Margaglione, M.; Montinaro, V. De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J. Allergy Clin. Immunol. 2013, 132, 6. [Google Scholar] [CrossRef]
- Diao, B.; Wang, C.; Tan, Y.; Chen, X.; Liu, Y.; Ning, L.; Chen, L.; Li, M.; Liu, Y.; Wang, G.; et al. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). MedRxiv 2020. [Google Scholar] [CrossRef]
- Nigro, E.; Scudiero, O.; Monaco, M.L.; Palmieri, A.; Mazzarella, G.; Costagliola, C.; Bianco, A.; Daniele, A. New insight into adiponectin role in obesity and obesity-related diseases. Biomed. Res. Int. 2014, 2014, 913. [Google Scholar] [CrossRef]
- Li, M.; Kim, D.H.; Tsenovoy, P.L.; Peterson, S.J.; Rezzani, R.; Rodella, L.F.; Aronow, W.S.; Ikehara, S.; Abraham, N.G. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008, 57, 1526–1535. [Google Scholar] [CrossRef] [PubMed]
- Iwata, M.; Hara, K.; Kamura, Y.; Honoki, H.; Fujisaka, S.; Ishiki, M.; Usui, I.; Yagi, K.; Fukushima, Y.; Takano, A.; et al. Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance. PLoS ONE 2018. [Google Scholar] [CrossRef]
- Toussirot, E.; Binda, D.; Gueugnon, C.; Dumoulin, G. Adiponectin in autoimmune diseases. Curr. Med. Chem. 2012, 19, 5474–5480. [Google Scholar] [CrossRef]
- Maeda, N.; Takahashi, M.; Funahashi, T.; Kihara, S.; Nishizawa, H.; Kishida, K.; Nagaretani, H.; Matsuda, M.; Komuro, R.; Ouchi, N.; et al. PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived Protein. Diabetes 2001, 50, 2094–2099. [Google Scholar] [CrossRef]
- Jayarathne, S.; Koboziev, I.; Park, O.H.; Oldewage-Theron, W.; Shen, C.L.; Moustaid-Moussa, N. Anti-Inflammatory and Anti-Obesity Properties of Food Bioactive Components: Effects on Adipose Tissue. Prev. Nutr. Food Sci. 2017, 22, 251–262. [Google Scholar] [CrossRef]
- Perrotta, F.; Nigro, E.; Mollica, M.; Costigliola, A.; D’agnano, V.; Daniele, A.; Bianco, A.; Guerra, G. Pulmonary hypertension and obesity: Focus on adiponectin. Int. J. Mol. Sci. 2019, 20, 912. [Google Scholar] [CrossRef]
- Monda, V.; Salerno, M.; Fiorenzo, M.; Villano, I.; Viggiano, A.; Sessa, F.; Triggiani, A.I.; Cibelli, G.; Valenzano, A.; Marsala, G.; et al. Role of sex hormones in the control of vegetative and metabolic functions of middle-aged women. Front. Physiol. 2017, 8, 773. [Google Scholar] [CrossRef]
- Bianco, A.; Mazzarella, G.; Turchiarelli, V.; Nigro, E.; Corbi, G.; Scudiero, O.; Sofia, M.; Daniele, A. Adiponectin: An attractive marker for metabolic disorders in chronic obstructive pulmonary disease (COPD). Nutrients 2013, 14, 4115–4125. [Google Scholar] [CrossRef]
- Desruisseaux, M.S.; Trujillo, M.E.; Tanowitz, H.B.; Scherer, P.E. Adipocyte, adipose tissue, and infectious disease. Infect. Immun. 2007, 75, 1066–1078. [Google Scholar] [CrossRef] [PubMed]
- Bianco, A.; Nigro, E.; Monaco, M.L.; Matera, M.G.; Scudiero, O.; Mazzarella, G.; Daniele, A. The burden of obesity in asthma and COPD: Role of adiponectin. Pulm. Pharmacol. Ther. 2017, 43, 20–25. [Google Scholar] [CrossRef] [PubMed]
- Sperandeo, R.; Maldonato, M.N.; Messina, A.; Cozzolino, P.; Monda, M.; Cerroni, F.; Romano, P.; Salerno, M.; Maltese, A.; Roccella, M.; et al. Orexin system: Network multi-tasking. Acta Med. Mediterr. 2018, 34, 349–356. [Google Scholar] [CrossRef]
- Ohashi, K.; Shibata, R.; Murohara, T.; Ouchi, N. Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol. Metab. 2014, 25, 348–355. [Google Scholar] [CrossRef] [PubMed]
- Daniele, A.; De Rosa, A.; Nigro, E.; Scudiero, O.; Capasso, M.; Masullo, M.; De Laurentiis, G.; Oriani, G.; Sofia, M.; Bianco, A. Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int. J. Biochem. Cell Biol. 2012, 44, 563–569. [Google Scholar] [CrossRef] [PubMed]
- Neumeier, M. Different effects of adiponectin isoforms in human monocytic cells. J. Leukoc. Biol. 2006, 79, 803–808. [Google Scholar] [CrossRef]
- Yang, J.; Hooper, W.C.; Phillips, D.J.; Talkington, D.F. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect. Immun. 2002, 70, 3649–3655. [Google Scholar] [CrossRef]
- Sessa, F.; Franco, S.; Picciocchi, E.; Geraci, D.; Chisari, M.G.; Marsala, G.; Polito, A.N.; Sorrentino, M.; Tripi, G.; Salerno, M.; et al. Addictions substance free during lifespan. Acta Med. Mediterr. 2018. [Google Scholar] [CrossRef]
- Mclaughlin, T.; Ackerman, S.E.; Shen, L.; Engleman, E. Role of innate and adaptive immunity in obesity-associated metabolic disease. J. Clin. Investig. 2017, 127, 5–13. [Google Scholar] [CrossRef] [PubMed]
- Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors. Nat. Immunol. 2010. [Google Scholar] [CrossRef] [PubMed]
- Ajuwon, K.M.; Spurlock, M.E. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, 1220–1225. [Google Scholar] [CrossRef] [PubMed]
- Masaki, T.; Chiba, S.; Tatsukawa, H.; Yasuda, T.; Noguchi, H.; Seike, M.; Yoshimatsu, H. Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice. Hepatology 2004, 40, 177–184. [Google Scholar] [CrossRef]
- Polito, R.; Nigro, E.; Elce, A.; Monaco, M.L.; Iacotucci, P.; Carnovale, V.; Comegna, M.; Gelzo, M.; Zarrilli, F.; Corso, G.; et al. Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis. Mediat. Inflamm. 2019, 2019, 934. [Google Scholar] [CrossRef]
- Garcia, P.; Sood, A. Adiponectin in Pulmonary Disease and Critically Ill Patients. Curr. Med. Chem. 2012. [Google Scholar] [CrossRef]
- Wulster-Radcliffe, M.C.; Ajuwon, K.M.; Wang, J.; Christian, J.A.; Spurlock, M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 2004, 316, 924–929. [Google Scholar] [CrossRef]
- Venkatesh, B.; Hickman, I.; Nisbet, J.; Cohen, J.; Prins, J. Changes in serum adiponectin concentrations in critical illness: A preliminary investigation. Crit. Care 2009. [Google Scholar] [CrossRef]
- Shore, S.A.; Terry, R.D.; Flynt, L.; Xu, A.; Hug, C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 2006, 118, 389–395. [Google Scholar] [CrossRef]
- Yilmaz, M.I.; Sonmez, A.; Caglar, K.; Gok, D.E.; Eyileten, T.; Yenicesu, M.; Acikel, C.; Bingol, N.; Kilic, S.; Oguz, Y.; et al. Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. Endocrine 2004, 25, 207–214. [Google Scholar] [CrossRef]
- Kanda, Y.; Matsuda, M.; Tawaramoto, K.; Kawasaki, F.; Hashiramoto, M.; Matsuki, M.; Kaku, K. Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: Implication of different mechanism from pioglitazone. Diabetes Res. Clin. Pract. 2008, 81, 13–18. [Google Scholar] [CrossRef] [PubMed]
- Monda, V.; Salerno, M.; Sessa, F.; Bernardini, R.; Valenzano, A.; Marsala, G.; Zammit, C.; Avola, R.; Carotenuto, M.; Messina, G.; et al. Functional Changes of Orexinergic Reaction to Psychoactive Substances. Mol. Neurobiol. 2018, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Salerno, M.; Villano, I.; Nicolosi, D.; Longhitano, L.; Loreto, C.; Lovino, A.; Sessa, F.; Polito, A.N.; Monda, V.; Chieffi, S.; et al. Modafinil and orexin system: Interactions and medico-legal considerations. Front. Biosci. Landmark 2019, 24, 564–575. [Google Scholar] [CrossRef]
- Hiuge, A.; Tenenbaum, A.; Maeda, N.; Benderly, M.; Kumada, M.; Fisman, E.Z.; Tanne, D.; Matas, Z.; Hibuse, T.; Fujita, K.; et al. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 635–641. [Google Scholar] [CrossRef]
- Koh, K.K.; Quon, M.J.; Lim, S.; Lee, Y.; Sakuma, I.; Lee, Y.H.; Han, S.H.; Shin, E.K. Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia. Atherosclerosis 2011, 214, 144–147. [Google Scholar] [CrossRef]
- Furuhashi, M.; Ura, N.; Higashiura, K.; Murakami, H.; Tanaka, M.; Moniwa, N.; Yoshida, D.; Shimamoto, K. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42, 76–81. [Google Scholar] [CrossRef]
- Yilmaz, M.I.; Sonmez, A.; Caglar, K.; Celik, T.; Yenicesu, M.; Eyileten, T.; Acikel, C.; Oguz, Y.; Yavuz, I.; Vural, A. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology 2007, 12, 147–153. [Google Scholar] [CrossRef]
- Bertozzi, G.; Salerno, M.; Pomara, C.; Sessa, F. Neuropsychiatric and Behavioral Involvement in AAS Abusers. A Literature Review. Medicina 2019, 55, 396. [Google Scholar] [CrossRef]
- Iwai, M.; Chen, R.; Imura, Y.; Horiuchi, M. TAK-536, a New AT1 Receptor Blocker, Improves Glucose Intolerance and Adipocyte Differentiation. Am. J. Hypertens. 2007, 20, 579–586. [Google Scholar] [CrossRef]
- Schupp, M.; Janke, J.; Clasen, R.; Unger, T.; Kintscher, U. Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-γ Activity. Circulation 2004, 109, 2054–2057. [Google Scholar] [CrossRef] [PubMed]
- Kwang, K.K.; Quon, M.J.; Sang, J.L.; Seung, H.H.; Jeong, Y.A.; Kim, J.A.; Chung, W.J.; Lee, Y.; Eak, K.S. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension. Diabetes Care 2007, 36, 1605–1607. [Google Scholar] [CrossRef]
- Nowak, Ł.; Adamczak, M.; Wiȩcek, A. Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension. Am. J. Hypertens. 2005, 18, 1470–1475. [Google Scholar] [CrossRef] [PubMed]
- Koh, K.K.; Quon, M.J.; Sakuma, I.; Lee, Y.; Lim, S.; Han, S.H.; Shin, E.K. Effects of simvastatin therapy on circulating adipocytokines in patients with hypercholesterolemia. Int. J. Cardiol. 2011, 146, 434–437. [Google Scholar] [CrossRef] [PubMed]
- Reis, C.E.G.; Bressan, J.; Alfenas, R.C.G. Effect of the diet components on adiponectin levels. Nutr. Hosp. 2010. [Google Scholar] [CrossRef]
- Parolini, C. Effects of fish n-3 PUFAs on intestinal microbiota and immune system. Mar. Drugs 2019, 27, 374. [Google Scholar] [CrossRef]
- Radzikowska, U.; Rinaldi, A.O.; Sözener, Z.Ç.; Karaguzel, D.; Wojcik, M.; Cypryk, K.; Akdis, M.; Akdis, C.A.; Sokolowska, M. The influence of dietary fatty acids on immune responses. Nutrients 2019, 11, 990. [Google Scholar] [CrossRef]
- Sansbury, B.E.; Spite, M. Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology. Circ. Res. 2016, 119, 113–130. [Google Scholar] [CrossRef]
- Sharma, S.; Chhibber, S.; Mohan, H.; Sharma, S. Dietary supplementation with omega-3 polyunsaturated fatty acids ameliorates acute pneumonia induced by Klebsiella pneumoniae in BALB/c mice. Can. J. Microbiol. 2013. [Google Scholar] [CrossRef]
- Jones, G.J.B.; Roper, R.L. The effects of diets enriched in omega-3 polyunsaturated fatty acids on systemic vaccinia virus infection. Sci. Rep. 2017. [Google Scholar] [CrossRef]
- Calder, P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013, 75, 645–662. [Google Scholar] [CrossRef] [PubMed]
- Singer, P.; Shapiro, H. Enteral omega-3 in acute respiratory distress syndrome. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12, 123–128. [Google Scholar] [CrossRef] [PubMed]
- Li, C.; Bo, L.; Liu, W.; Lu, X.; Jin, F. Enteral immunomodulatory diet (omega-3 fatty acid, γ-linolenic acid and antioxidant supplementation) for acute lung injury and acute respiratory distress syndrome: An updated systematic review and meta-analysis. Nutrients 2015, 7, 5572–5585. [Google Scholar] [CrossRef] [PubMed]
- Dushianthan, A.; Cusack, R.; Burgess, V.A.; Grocott, M.P.W.; Calder, P.C. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults. Cochrane Database Syst. Rev. 2019, 1, 41. [Google Scholar] [CrossRef] [PubMed]
- García De Acilu, M.; Leal, S.; Caralt, B.; Roca, O.; Sabater, J.; Masclans, J.R. The Role of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with Acute Respiratory Distress Syndrome: A Clinical Review. Biomed. Res. Int. 2015, 2015, 750. [Google Scholar] [CrossRef]
- Alvarado, A.; Arce, I. Antioxidants in respiratory diseases: Basic science research and therapeutic alternatives. Clin. Res. Trials 2016. [Google Scholar] [CrossRef]
- Christofidou-Solomidou, M.; Muzykantov, V.R. Antioxidant strategies in respiratory medicine. Treat. Respir. Med. 2006, 5, 47–78. [Google Scholar] [CrossRef]
- Galvão, A.M.; de Andrade, A.D.; de Souza, M.B.; da Silva, K.E.R.; de Andrade Bezerra, A.; de Melo, J.F.; de Morais, N.G.; da Costa, T.B.; de Castro, C.M.M.B. Antioxidant supplementation for the treatment of acute lung injury: A meta-analysis. Rev. Bras. Ter. Intensiva 2011, 23. [Google Scholar] [CrossRef]
- Carr, A.C. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit. Care 2020, 24, 133. [Google Scholar] [CrossRef]
- Yang, N.; Zhang, H.; Cai, X.; Shang, Y. Epigallocatechin-3-gallate inhibits inflammation and epithelial-mesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma. Int. J. Mol. Med. 2018, 41, 818–828. [Google Scholar] [CrossRef]
- Ling, L.J.; Lu, Y.; Zhang, Y.Y.; Zhu, H.Y.; Tu, P.; Li, H.; Chen, D.F. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling. Phytomedicine 2020, 67, 150. [Google Scholar] [CrossRef] [PubMed]
- Whitsett, J.A.; Alenghat, T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat. Immunol. 2015, 16, 27–35. [Google Scholar] [CrossRef] [PubMed]
- Kreda, S.M.; Davis, C.W.; Rose, M.C. CFTR, mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb. Perspect. Med. 2012, 2, 589. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez Capote, K.; McCormack, F.X.; Possmayer, F. Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain. J. Biol. Chem. 2003, 278, 20461–20474. [Google Scholar] [CrossRef]
- Weismann, D.; Binder, C.J. The innate immune response to products of phospholipid peroxidation. Biochim. Biophys. Acta Biomembr. 2012, 1818, 2465–2475. [Google Scholar] [CrossRef]
- Shirey, K.A.; Lai, W.; Scott, A.J.; Lipsky, M.; Mistry, P.; Pletneva, L.M.; Karp, C.L.; McAlees, J.; Gioannini, T.L.; Weiss, J.; et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 2013. [Google Scholar] [CrossRef]
- Van Lenten, B.J.; Wagner, A.C.; Navab, M.; Anantharamaiah, G.M.; Hui, E.K.W.; Nayak, D.P.; Fogelman, A.M. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 2004, 110, 3252–3258. [Google Scholar] [CrossRef]
- Imai, Y.; Kuba, K.; Neely, G.G.; Yaghubian-Malhami, R.; Perkmann, T.; van Loo, G.; Ermolaeva, M.; Veldhuizen, R.; Leung, Y.H.C.; Wang, H.; et al. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury. Cell 2008, 113, 235–249. [Google Scholar] [CrossRef]
- Shaikh, S.R.; Fessler, M.B.; Gowdy, K.M. Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation. J. Leukoc. Biol. 2016. [Google Scholar] [CrossRef]
- Fessler, M.B.; Summer, R.S. Surfactant lipids at the host-environment interface metabolic sensors, suppressors, and effectors of inflammatory lung disease. Am. J. Respir. Cell Mol. Biol. 2016, 54, 624–635. [Google Scholar] [CrossRef]
- Minihane, A.M.; Vinoy, S.; Russell, W.R.; Baka, A.; Roche, H.M.; Tuohy, K.M.; Teeling, J.L.; Blaak, E.E.; Fenech, M.; Vauzour, D.; et al. Low-grade inflammation, diet composition and health: Current research evidence and its translation. Br. J. Nutr. 2015, 114, 999–1012. [Google Scholar] [CrossRef] [PubMed]
- Caron, E.; Desseyn, J.L.; Sergent, L.; Bartke, N.; Husson, M.O.; Duhamel, A.; Gottrand, F. Impact of fish oils on the outcomes of a mouse model of acute Pseudomonas aeruginosa pulmonary infection. Br. J. Nutr. 2015. [Google Scholar] [CrossRef] [PubMed]
- Tiesset, H.; Bernard, H.; Bartke, N.; Beermann, C.; Flachaire, E.; Desseyn, J.-L.; Gottrand, F.; Husson, M.-O. (n-3) Long-Chain PUFA Differentially Affect Resistance to Pseudomonas aeruginosa Infection of Male and Female cftr–/–Mice. J. Nutr. 2011, 141, 1101–1107. [Google Scholar] [CrossRef] [PubMed]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef]
- Rotzinger, D.C.; Beigelman-Aubry, C.; von Garnier, C.; Qanadli, S.D. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography. Thromb. Res. 2020, 190, 58–59. [Google Scholar] [CrossRef]
- Klok, F.A.; Kruip, M.J.H.A.; van der Meer, N.J.M.; Arbous, M.S.; Gommers, D.A.M.P.J.; Kant, K.M.; Kaptein, F.H.J.; van Paassen, J.; Stals, M.A.M.; Huisman, M.V.; et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020. [Google Scholar] [CrossRef]
- Mehta, P.; McAuley, D.F.; Brown, M.; Sanchez, E.; Tattersall, R.S.; Manson, J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020, 395, 1033–1034. [Google Scholar] [CrossRef]
- Imai, Y. Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2015, 1851, 496–502. [Google Scholar] [CrossRef]
- Hecker, M.; Linder, T.; Ott, J.; Walmrath, H.D.; Lohmeyer, J.; Vadász, I.; Marsh, L.M.; Herold, S.; Reichert, M.; Buchbinder, A.; et al. Immunomodulation by lipid emulsions in pulmonary inflammation: A randomized controlled trial. Crit. Care 2015, 19, 226. [Google Scholar] [CrossRef]
- Chan, K.H.; Yeung, S.C.; Yao, T.J.; Ip, M.S.M.; Cheung, A.H.K.; Chan-Yeung, M.M.W.; Mak, J.C.W.; Lam, W.K.; Yew, W.W.; Wong, P.C.; et al. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int. J. Tuberc. Lung Dis. 2010, 14, 1193–2000. [Google Scholar]
- Fragopoulou, E.; Panagiotakos, D.B.; Pitsavos, C.; Tampourlou, M.; Chrysohoou, C.; Nomikos, T.; Antonopoulou, S.; Stefanadis, C. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: The ATTICA study. J. Nutr. Biochem. 2010, 21, 285–289. [Google Scholar] [CrossRef] [PubMed]
- Adamczak, M.; Rzepka, E.; Chudek, J.; Wiȩcek, A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin. Endocrinol. 2005, 62, 114–118. [Google Scholar] [CrossRef] [PubMed]
- Mirco, N.; Andrea, C.; Angelo, G.; Pietro, B.; Federico, L.; Michele, P.; Giuseppe, G.; Daniele, B.; Francesco, F.; Richard, N.; et al. At the Epicenter of the Covid-19 Pandemic and Humanitarian Crises in Italy: Changing Perspectives on Preparation and Mitigation. Catal. Non-Issue Content 2020, 1, 80. [Google Scholar] [CrossRef]
- Guan, W.; Liang, W.; Zhao, Y.; Liang, H.; Chen, Z.; Li, Y.; Liu, X.; Chen, R.; Tang, C.; Wang, T.; et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur. Respir. J. 2020, 55, 20. [Google Scholar] [CrossRef] [PubMed]


Dietary Supplementation | Main Natural Sources | Potential Effects in COVID-19 Infection |
---|---|---|
Flavonoids | Red wine, oranges, red fruits and vegetables | Reduces inflammation and immune response, blocking nuclear NF-κB translocation |
Polyphenols | Green tea, broccoli, apples | |
Vitamin C | Oranges, lemons, mangoes |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).